NCIt definition : A regimen consisting of letrozole and ribociclib that may be used in the treatment
of hormone receptor (HR)-positive advanced or metastatic breast cancer, and endometrial
cancer.;
https://www.has-sante.fr/jcms/p_3404153/fr/kisqali-ribociclib-cancer-du-sein 2023 false false false France insurance, health, reimbursement treatment outcome administration, oral antineoplastic agents protein kinase inhibitors ribociclib antineoplastic combined chemotherapy protocols Letrozole Letrozole/Ribociclib Regimen hormone-receptor-positive, HER2-negative locally advanced or metastatic breast cancer neoplasm metastasis evaluation of the transparency committee breast cancer ribociclib breast neoplasms
Est indiqué pour
